# A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia

> **NCT00357825** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 246 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** [S,S]-Reboxetine

## Key facts

- **NCT ID:** NCT00357825
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 246 (—)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00357825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00357825, "A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00357825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*